3 Recruiting Esophageal Adenocarcinoma Clinical Trials in New York
Explore active esophageal adenocarcinoma research studies enrolling across New York. Verify eligibility and contact site coordinators.
📍 Find Near Me by DistanceRecruiting Esophageal Adenocarcinoma Studies in New York
🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
Adjuvant Trastuzumab Deruxtecan (Enhertu) & Nivolumab For Patients Who Are Disease Free After Completion of Trimodality Treatment For HER-2+ Cancers of Esophagus & Gastroesophageal Junction
📍 Weill Cornell Medicine/New York-Presbyterian — New York, New York
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Study of Suratadenoturev (OBP-301) in Combination With Pembrolizumab in Esophagogastric Adenocarcinoma
📍 Weill Cornell Medicine/NewYork-Presbyterian Hospital — New York, New York
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma
📍 Roswell Park Cancer Institute — Buffalo, New York
View Study & Checklist ➔